Loading

Journal of Autoimmunity and Research

Gene Expression and Pathway Analysis of Radiation-Induced Apoptosis in C-4 I Cervical Cancer Cells

Case Report | Open Access | Volume 4 | Issue 1

  • 1. Institute of Science, Istanbul University, Turkey
  • 2. Department of Science, Istanbul University,Turkey
  • 3. Department of Radiation Oncology, Istanbul University, Turkey
+ Show More - Show Less
Corresponding Authors
Walid Mahmoud Khalilia, Institute of Science,Department of Radio biology, Istanbul University,A-Blok, 34134, Vezneciler-Fatih, Istanbul – Turkey, Tel:95334957323; Fax: 90-212 5280527
Abstract

Objective: The present study aimed to determine whether a single-fraction of gamma radiation could induce the expression of specific genes involved in apoptosis signaling pathways, which helps us in better understanding cancer dynamics and treatment targets for cancer.

Materials and methods: C-4 I cells were treated with a single fraction of gamma radiation at various doses (0, 2, 8, 16, 32 and 64 Gy) and investigated after incubation for five time periods (0, 24, 48, 60 and 72 h). The proliferation of C-4 I cells was measured by MTT assay, but apoptotic index (AI) and apoptotic morphological features were assessed by fluorescent microscopy. Moreover, the expression of the apoptotic genes was evaluated using microarray and qRT-PCR molecular processes. In addition, gene ontology and pathway analysis were performed.

Results: Gamma irradiation inhibits proliferation of C-4 I cells in a dose- and timedependent manner, and 16 Gy was identified as the IC50 and AI dose. Microarray and qRT-PCR results monitored the expression of some factors that are known apoptosis activators were up regulated by gamma radiation treatment, whereas some anti-apoptosis members were down regulated.

Pathway analysis identified that significant pathways related to apoptosis, cell cycle and P53 were significantly enriched.

Conclusions: These results provide evidence that gamma radiation directly induces anti-proliferative effects by altering the expression of genes associated with cell proliferation and apoptosis pathways in C-4 I cells.

Keywords

•    Apoptosis
•    C-4 I cells
•    Gamma radiation
•    Microarray
•    qRT-PCR

Citation

Khalilia WM, Özcan G, Karaçam S (2017) Gene Expression and Pathway Analysis of Radiation-Induced Apoptosis in C-4 I Cervical Cancer Cells. J Autoimmun Res 4(1): 1014.

ABBREVIATIONS

IR: Ionizing Radiation; TNF: Tumor Necrosis Factor; MTT: 3-[4, 5-Dimethylthiazol-2-yl]-2, 5-Diphenyltetrazolium bromide; DAPI: 4,6-Diamidino-2-phenylindole; AI: Apoptotic Index; FC: Fold Change; GO: Gene Ontology; mCt: Mean threshold cycle.

INTRODUCTION

Radiation therapy is one of the most common treatments for cancer, used in more than half of all cancer cases, in which highenergy rays used to destroy cancer cells in the body. Radiotherapy is the most effective therapy for cervical cancer in advanced stages [1]. Ionizing radiation (IR) leads to many cellular changes like activates signaling pathways in the nucleus as a result of DNA damage, and signaling pathways initiated at the level of the plasma membrane. DNA damage result in a coordinate network of signal transduction pathways involved in cell cycle arrest, apoptosis, stress response and the activation of DNA repair processes. However, the plasma membrane signaling pathways through activation of some receptors results in activation of the initiator caspase-8 which can propagate the apoptosis signal by direct cleavage of downstream effectors caspases. IR can also induce apoptosis via the generation of free radical oxygen species, which gives rise to a variety of cellular lesions including both DNA and membrane damage [2]. Previous studies suggest that changes in membrane fluidity, superoxide dismutase (SOD) and calcium level were involved in the mechanism of radiation induced cervical cells apoptosis. Moreover, apoptotic sensitivity of these cells after the first dose of radiation treatment showed a direct correlation with the radiation treatment outcome in patients after completion of radiotherapy protocol (70 Gy) [3].

Apoptosis is the major mode of programmed cell death, and is characterized by a series of morphological hallmarks, including cell shrinkage, nuclear DNA condensation and fragmentation, as well as plasma membrane blebbing, which formed the apoptotic bodies. There are two main apoptotic pathways: the extrinsic initiated by death receptors and the intrinsic pathway initiated by mitochondrial events. However, there is evidence that the two pathways are linked and that molecules in one pathway can affect the other. Although, there is an additional apoptotic pathway under studies yet [4].

Apoptosis is a genetically regulated biological process. Changes on apoptotic cells occur after a series of events regulated by caspases and various cell signals that regulate pro-apoptotic and anti-apoptotic proteins. Extrinsic and intrinsic pathways can be activated separately, but most caspases activation is common in an apoptotic pathway. Ligand-bound tumor necrosis factor (TNF) receptors initiate apoptosis by recruiting fas associated death domain (FADD) and other death domain adaptor proteins that then recruit and activate caspases [5,6]. Environmental stresses trigger BCL2 protein oligomerization and insertion into the mitochondrial membrane [7,8], releasing apoptotic protease activating factor 1 (APAF1) and other caspase activation and recruitment domain (CARD) family members that also oligomerize to recruit and activate caspases [4,9,10]. Caspases promote a proteolysis cascade that degrades cellular protein targets, while the inhibitor of apoptosis protein (IAP) family directly inhibits caspases. One of the major apoptosis signaling pathways involves the P53 tumor suppressor. Tumor protein P53 is a nuclear transcription factor that regulates the expression of a wide variety of genes involved in apoptosis in response to genotoxic or cellular stress [2,11]. Understanding apoptosis is often considered a key to understanding the genesis of tumors and to devising innovative strategies for cancer treatment [12].

Therefore, the present study aimed to determine whether gamma radiation could induce the expression of specific genes involved in apoptosis signaling pathways. Identifying up-regulated or down-regulated genes helps us in better understanding the cancer dynamics and helps identify markers and treatment targets for cervical cancer.

MATERIALS AND METHODS

Cell culture and γ-60co irradiation

Cervical cancer C-4 I cell line (ATCC), maintained at 37°C in Waymouth’s MB 752/1 (Sigma) supplemented with 10% fetal bovine serum (Gibco Lab.), 100 IU/ml penicillin (Pronapen, Pfizer) and 100 go/ml streptomycin (streptomycin sulfate, ?.E. Ulagay) in a humidified atmosphere of 5% CO2 . Cells were “passaged” every 2 to 3 days using 0.25% trypsin (Sigma) to detach the cells from the flasks [13]. Before the cell proliferation and apoptosis assays, and prior to evaluating genes expression, C-4 I cells were placed in a 6-well plate at a density of 2.5×105 cells per well. After overnight incubation, cells were irradiated at the Istanbul University, Faculty of Medicine, Radiation Oncology, Turkey (Cirus, CCR CisBio, Canada) by different dozes of gamma radiation (2, 8, 16, 32 and 64 Gy) with a dose rate of 100 cGy/min. and incubated for 24, 48, 60 and 72 h, control group (0 Gy) were not irradiated. After irradiation, cell cultures were replaced in the incubator and maintained at 37°C under 5% CO2 . For the irradiation groups, the time when the irradiation was finished was set as time 0 [14,15].

Cytotoxicity and cell proliferation

Cell proliferation was evaluated using the 3-[4, 5-Dimethylthiazol-2-yl]-2, 5-Diphenyltetrazolium bromide (MTT; Sigma) cell viability assay, as previously described [16].

Observation of morphological changes

The cellular morphological changes were observed using phase contrast microscopy and fluorescent microscopy [13].

Apoptotic index (AI)

After irradiation and incubation, C-4 I cells were trypsinized, washed with mixture of 200 µl methanol: farnesyl thiosalicylic acid (FTS) (1:1), fixed in iced pure methanol, stained with 50μg/ mL of 4,6-diamidino-2-phenylindole (DAPI, Sigma) in dark for 20 minutes, and then the slides were washed in phosphate buffered saline (PBS). DAPI is a blue-fluorescent DNA stain that exhibits ~20-fold enhancement of fluorescence upon binding to AT regions of dsDNA. It is commonly used as a nuclear counter stain in fluorescence microscopy. Because of its high affinity for DNA, it is also frequently used for counting cells, measuring apoptosis, sorting cells based on DNA content.

The nuclear morphology was observed under a fluorescent microscope (λex. 358 nm, λem. 461 nm). And apoptotic cells were identified by their characteristic fragmented chromatin masses. Small groups of apoptotic bodies were counted as remnants of one apoptotic cell. Apoptotic cells were counted among 100 cells randomly. Apoptosis was expressed as the number of apoptotic nuclei per number of total nuclei counted in the same microscopic field. This AI was a mean of three independent experiments [12,16].

Isolation and quantification of total RNA

C-4 I cells were plated in a 6-well plate at a density of 2.5×105 cells per well. After overnight incubation cells were irradiated by 16 Gy single dose of γ-60Co radiation and incubated for 60 hours, control group (0 Gy) were not irradiated. After wash with PBS, 6x106 cells were harvested from samples and total RNA was extracted using High Pure RNA Isolation kit (Roche) according to the manufacturer’s instructions. RNA concentrations were determined with visible spectrophotometer (GBC Cintra 20). RNA purity was checked by measurement of the A 260/280 nm ratio, which was routinely in the range of 1.8-2.0. Purified total RNA samples were stored frozen at -80°C until needed for subsequent gene expression profiling [17].

Bead array technology

Human HT-12 Expression Bead Chips with the Illumina Whole-Genome Gene Expression Direct Hybridization Assay (Illumina) system were used to evaluate the expression patterns of more than 48,000 transcripts in C-4 I cells, according to the manufacturer’s instructions. Complementary DNA (cDNA) was produced following reverse transcription from 100 ng of total RNA and then fluorescent cRNA was performed according to the TargetAmp™-Nano Labeling Kit (Illumina). 750 ng cRNA per sample, which was then hybridized to Human HT-12 Illumina® Expression BeadChip® (Illumina) [18].

Bead Chip scanning and data analysis

Microarray slides were then scanned using the Illumina iScan System (Illumina). For gene expression analysis and the generation of gene lists for fold change (FC), functional annotation and pathway analysis, microarray data were processed in a Genome Studio module (V2011.1; Illumina). The signal was taken as the measure of mRNA abundance derived from the level of gene expression. Raw data were adjusted by using Box Plots normalization. Significance levels of differences between the groups were calculated for each probe set using FC and P-values (p < 0.05 and FC ≥ |2|) [19,20].

Bioinformatics analysis

Differentially expressed genes were used as input for a network analyses that were performed with Gene Ontology (GO) network building tools (PANTHER, http://www.pantherdb.org/ pathway/). GO and pathway analysis were performed on the up-regulated and down-regulated genes. Significant functions were identified based on p-value (p < 0.05) [21].

qRT-PCR technology

A Real Time Ready Apoptosis Panel (Human Apoptosis Panel, 96, Roche) was used to assess expression patterns of apoptosisrelated genes in C-4 I cells, according to the manufacturer’s instructions. The panel is designed for expression profiling of genes that play a major role in apoptotic processes in human cells. On the plate, assays for the 84 apoptosis-related genes are grouped to reflect the various protein families and pathways involved in apoptosis.

cDNA synthesis and qRT-PCR set up

First-strand cDNA was synthesized from 3 μg total RNA and a primer was performed using the cDNA synthesis kit (Transcriptor High Fidelity cDNA Synthesis kit, Roche) following manufacturer instructions [22].

Eighty-four apoptosis-related genes were quantified using a Real Time Ready Apoptosis Panel (Human Apoptosis Panel, 96, Roche) according to manufacturer instructions. PCR mix for one reaction (20 μl) that was done by adding 2 μl of primer-probe mix and 10 μl probe and 3 μl dH2O to a total volume of 15 μl in a 1.5 ml reaction tube on ice. After mixing carefully, the 15μl mixture was pipetted into each well of the 96 well plate (Light Cycler 480® Multiwell plate, Roche). After that a 5 μl cDNA template was added to each well, and the plate was sealed with sealing foil and centrifuged for 2 minutes at 1500 xg followed by loading the multi well plate into the instrument (Light Cycler 480® Instrument II, Roche). All reactions were run for one cycle of PCR that consisted of enzyme activation and template denaturation for 10 minutes at 95o C, followed by 40 cycles of PCR. Each cycle consisted of 30 second annealing at 60o C and an extension phase at 72o C for 1 second followed by 20 seconds at 85°C to denature the doublehelix PCR product. Fluorescence data was acquired after each annealing and extension step. Results were expressed using the comparative threshold (Ct) method [23].

Quantitative data analysis of qRT-PCR

Calculation of gene expression was carried out using Ct cycle. The mean threshold cycle (mCt) was obtained from triplicate amplifications during the exponential phase. The mCt value of reference genes was then subtracted from mCt value of the target genes to obtain the ΔCt and ΔΔCt values of each sample, which were calculated from corresponding Ct values; where ΔΔCt= [mCt target – mCt reference] (treated sample) - [mCt target – mCt reference] (untreated sample). Finally, a target gene expression/ reference gene expression ratio was calculated using the ratio formula (ratio = 2 -ΔΔCt), which was used for gene expression analysis and the generation of gene lists for FC (FC ≥ |2|) [24].

Statistical analysis

For the experimental cell proliferation and AI data sets, statistical significance was determined using one-way ANOVA and unpaired Students’t test (p < 0.05).

RESULTS AND DISCUSSION

Initial studies on the treatment of a cervical cancer adenocarcinoma C-4 I cells with 2, 8, 16, 32 and 64 Gy of γ-60Co radiation for a duration of 0-72 hours indicated tha tradiation inhibits C-4 I cells proliferation and apoptosis was elevated by time and γ-60Co radiation dose rate, with maximum levels observed 60 hours after irradiation.

Cell proliferation

MTT assay showed that radiation inhibited proliferation of C-4 I cells. Our results showed that C-4 I cell survival rates of all irradiated groups at 0-hour post-irradiation time were nearly the same at more than 70%, while the cell survival at 24 hours postirradiation time in the 16, 32 and 64 Gy groups were much lower, less than 70%. Our experiments showed that a radiation dose of 16 Gy induced cell death in 50% of C-4 I cells at 24 hours postirradiation time compared with control group (0 Gy). A such a 16 Gy γ-60Co radiation dose was determined as the IC50 dose (Figure 1).

Effect of ?-60Co radiation on survival of C-4 I cells at 0 and 24 hours post-irradiation time. Cell survival was determined by MTT assay. Results are presented as a percent of control. Control is 100% in all time points. The experiment was repeated triple with similar results.

Figure 1: Effect of γ-60Co radiation on survival of C-4 I cells at 0 and 24 hours post-irradiation time. Cell survival was determined by MTT assay. Results are presented as a percent of control. Control is 100% in all time points. The experiment was repeated triple with similar results.

Microscopy and apoptotic index (AI)

Fluorescent images of the nuclear morphology of C-4 I cells in control and in all irradiated groups (2, 8, 16, 32 and 64 Gy) at 60 hours post-irradiation time after DAPI staining. The nuclei were normal in the control group; whereas the nuclei became condensed or fragmented in the all irradiated groups (2, 8, 16, 32 and 64 Gy) (Figure 2).

Representative fluorescent images of the nuclear morphology of C-4 I cells in the control and all irradiated (2, 8, 16, 32 and 64 Gy) groups at 60 hours post-irradiation time, following DAPI staining. In control group, cellular nuclear chromatin homogeneous distribution; whereas the nuclei became condensed or fragmented in the all irradiated groups observed by a fluorescence microscope (X1000). Arrows represent apoptotic cells. The experiment was repeated triple with similar results.

Figure 2: Representative fluorescent images of the nuclear morphology of C-4 I cells in the control and all irradiated (2, 8, 16, 32 and 64 Gy) groups at 60 hours post-irradiation time, following DAPI staining. In control group, cellular nuclear chromatin homogeneous distribution; whereas the nuclei became condensed or fragmented in the all irradiated groups observed by a fluorescence microscope (X1000). Arrows represent apoptotic cells. The experiment was repeated triple with similar results.

AI was induced by γ-60Co radiation, and increased in a radiation dose and time-dependent manner (Figure 3).

Measure of apoptotic index by counting 100 of C-4 I cells in the control and all irradiated (2, 8, 16, 32 and 64 Gy) groups at 24, 48, 60, and 72 hours post-irradiation time, following DAPI staining under fluorescence microscope (×1000). The data shown represents mean of three independent experiments.

Figure 3: Measure of apoptotic index by counting 100 of C-4 I cells in the control and all irradiated (2, 8, 16, 32 and 64 Gy) groups at 24, 48, 60, and 72 hours post-irradiation time, following DAPI staining under fluorescence microscope (×1000). The data shown represents mean of three independent experiments.

The highest AI values (at 60 and 72 hours post-irradiation time) were reached more than 50% for 64 Gy and 32 Gy. While, at 0 and 24 hours post-irradiation time the lowest AI values, less than 20% for all irradiated groups. Apoptosis levels remained nearly stable for durations ranging from 60 to72 hours post-irradiation time (Figure 3).

Measure of apoptotic index by counting 100 of C-4 I cells in the control and all irradiated (2, 8, 16, 32 and 64 Gy) groups at 24, 48, 60, and 72 hours post-irradiation time, following DAPI staining under fluorescence microscope (×1000). The data shown represents mean of three independent experiments.

Figure 3: Measure of apoptotic index by counting 100 of C-4 I cells in the control and all irradiated (2, 8, 16, 32 and 64 Gy) groups at 24, 48, 60, and 72 hours post-irradiation time, following DAPI staining under fluorescence microscope (×1000). The data shown represents mean of three independent experiments.

16 Gy γ-60Co radiation dose was determined to be the optimum AI value in our current study.

Gamma radiation cytotoxicity and AI considering 16 Gy as the IC50 and optimum AI dose, based on these data, 16 Gy group at 60-hour time point was chosen for further studies.

In the present study, C-4 I cell growth was depressed by large doses of γ-60Co radiation (8, 16, 32 and 64 Gy), but not by low doses (2) at 24 hours post-irradiation time. These results are in agreement with those of previous studies [25]. In addition to decreasing cell proliferation and viability, a single dose of γ-60Co radiation induced apoptosis in C-4 I cells. From our results the percentage of condensed or fragmented nuclei increased with time and dose of radiation. These results are consistent with those of previous studies [26].

The percentages of apoptotic cells in AI assay was showed that the level of apoptosis increased with γ-60Co radiation dose. These results indicate that irradiation primarily affects the C-4 I cell proliferation by inducting cell apoptosis. These results are consistent with those of previous studies [12].

Gene expressions by microarray and pathway analysis

For statistical analysis of microarray data, the study began with 47 231probes, which filtered based on the expression levels from the normalized data. Probes received radiation under 20% was filtered and the study was continued with 47 088 total probe. If any sample received radiation above 20%was allowed to pass through the filter and there by minimize loss of probes. Genes with a standard deviation greater than 0.1 were removed from further analysis. Finally, from the total 47 088 probes 47 071 probes were filtered, and the study were continued with this number of probes [27].

At 60 hours after exposure to 16 Gy of γ-60Co radiation in C-4 I cells, the microarray showed that, 105 of the probes expression increased according to the control group (had 2-fold up regulation), and 210 probes expression was lower than the control group (had 2-fold down regulation) (Table 1). In particular, ITPR1 and KREMEN2 had significant up regulation, whereas expressions of MAPK3, MKNK2, SNF and CAP2P were down regulated.

Cellular response to γ-60Co radiation is mediated via genes that control complex regulatory pathways such as cell cycle progression, apoptosis, or DNA repair. The relative contribution of changes in the expression of these genes on signaling pathways is unknown [28].

In this study ITPR1, KREMEN2 gene members expression triggers the death of C-4 I cells by WNT and PDGF signaling pathways in γ-60Co radiation treated C-4 I cells compared to control cells. The type 1 inositol-1,4,5-trisphosphate receptor (ITPR1) mediates calcium release from the endoplasmic reticulum (ER). ITPR1receptor located on the ER membrane that is critical to calcium homeostasis, was reported to be cleaved during apoptosis in Jurkat cells [29].

Mapk3, Mknk2, Snf ve Cap2p gene members of the cell Glycolysis,TGF-β, WNT, PDGF, P38 MAPK, Oxidative stress response andP53signaling pathwayswere significantly downregulated in γ-60Co radiation treated C-4 I compared to control C-4 I cells.

MAPK3 regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals [30]. ERK-1 MAP kinase prevents TNF-induced apoptosis through bad phosphorylation and inhibition of Bax translocation in HeLa Cells [ 31].

MKNK2 protein is one of the downstream kinases activated by mitogen-activated protein (MAP) kinases. It playing important roles in the initiation of mRNA translation, oncogenic transformation and malignant cell proliferation [32].

GO and pathways analysis identified the cell glycolysis related pathways were significantly down-regulated in gamma radiation treated C-4 I cells compared to control cells. Several gene members of the cell glycolysis related pathways were significantly down-regulated in gamma radiation treated C-4 I cells compared to control cells. Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation of ATP as a main source of their energy supply. Thus, combination of glycolytic inhibitors and DNA-damaging agents seems to be an attractive therapeutic strategy to effectively kill cancer cells [33].

Gene expressions by qRT-PCR

To gain insights into radiation response, qRT-PCR was used to assess expression patterns of many apoptosis-related genes, grouped to reflect the various protein families and pathways involved in apoptosis, in C-4 I cells at 60 hours after exposure to 16 Gy single dose of γ-60Co radiation (Figure 4).

Pie charts showing pathways altered in C-4 I cells at 60 hours after exposure to 16 Gy single dose of gamma radiation, as compared to control cells. Chart was generated from the microarray data analysis according to PANTHER pathway enrichment analysis. (A) were performed on up-regulated genes. (B) Were performed on down-regulated genes.

Figure 4: Pie charts showing pathways altered in C-4 I cells at 60 hours after exposure to 16 Gy single dose of gamma radiation, as compared to control cells. Chart was generated from the microarray data analysis according to PANTHER pathway enrichment analysis. (A) were performed on up-regulated genes. (B) Were performed on down-regulated genes.

In this part of the present study, it was hypothesized that apoptosis-related gene expression levels in C-4 I cells were affected by γ-60Co radiation. Figure (5) shows that the apoptosisrelated genes Bid, Bik, Pmi?p1, Traf2, Traf3, Traf6, Tnf, Tnfrsf10b, Tnfrsf10d, Tp53?3, Socs2, Socs3, Nf-kb1, Nf-kb2, Cradd, Pten,Dffa, Fam96a and Fam96b were up-regulated (FC ≥2). While other apoptosis-related Bcl2l2, Bcl2l13, Bag1, Bad, Cad, Hrk, Fadd, Traf7, Tp53, Stat5b and Relb gene expression levels were down regulated (FC ≥ -2) (Figure 5).

Fold changes of genes involved in apoptosis in C-4 I cells at 60 hours after exposure to 16 Gy single dose of gamma radiation.

Figure 5: Fold changes of genes involved in apoptosis in C-4 I cells at 60 hours after exposure to 16 Gy single dose of gamma radiation.

There are two main apoptotic pathways: The extrinsic apoptotic pathway involves engagement of particular death receptors that belong to the TNFR (Tumor Necrosis Factor Receptor) family and, through the formation of the DISC (Death Inducing-Signaling-Complex), leads to a cascade of activation of Caspases, including Caspase 8 and Caspase 3, which in turn induce apoptosis. Our results were in agreement with previous results that found the death-domain-containing receptor for TRAIL (TNF-Related Apoptosis-Inducing Ligand) was induced by P53 in response to DNA damage and in turn promotes cell death through Caspase 8. Thus, the extrinsic apoptotic pathway was activated by inducing the expression of TRAIL death receptor in response to γ-60Co radiation of C-4 I cells [34,35].

The Intrinsic apoptotic pathway is dominated by the BCL2 family of proteins, which governs the release of Cytochrome-C (CytoC) from the mitochondria. BCL2 family comprises antiapoptotic (pro-survival) and pro-apoptotic members. From our results radiation induced a pro-apoptotic BID and BIK genes expression in C-4 I cells. BID, a critical link between the extrinsic apoptosis pathway with the mitochondrial pathway in certain cell types [36]. This gene encodes a death agonist that hetero dimerizes with either agonist BAX or antagonist BCL2. It is a mediator of mitochondrial damage induced by caspase-8 [37,38].

BIK, as a BH-only pro-apoptotic member, binds with BCL-2, BCL2L1 or MCL-1 to replace BAX or BAK, which forms BAX/ BAK oligomerization and then triggers mitochondrial outer membrane permeabilization, cytochrome c into cytoplasm, caspase-9 activation and at last cell apoptosis [39]. Hur et al. [40], suggest that expression of BIK in human breast cancer cells is regulated at the mRNA level by a mechanism involving a non transcriptional activity of P53 by gamma radiation and by proteasomal degradation of BIK protein. Jiao et al. [41], generated a novel mutant form of BIK, as a therapeutic gene for breast cancer. Therefore, BIK and its mutant forms can be a novel therapeutic gene in cervix cancer targeted gene therapy.

Our results also suggested that radiation decreased gene expression of the BCL-2 family anti-apoptotic members. In a study conducted by Loriot et al. [42], radiotherapy has a critical role in the treatment of small-cell lung cancer (SCLC). The effectiveness of radiation in SCLC remains limited as resistance results from defects in apoptosis. Their results show the inhibition of BCL-2/ BCL-XL can enhance radiosensitivity of SCLC lung cancer cells in vitro and in vivo.

In another study Wu et al. [43], support the combination of radiation and pro-survival Bcl-2 family inhibitor as a potential novel therapeutic strategy in the local-regional management of breast cancer.

Table 1: Differentially expressed genes in 16 Gy C-4 I compared to C-4 I control groups from microarray data analysis.

Down-regulated and Up- regulated Genes
Gene Symbol FC Expression Changed Gene Symbol FC Expression Changed Gene Symbol FC Expression Changed
LOC644237 -3.79265 down TIMM17B -2.15878 down TNFRSF12A 2.291376 up
MKNK2 -2.14563 down MTP18 -2.39648 down TFRC 2.985572 up
MYO18A -2.62235 down FAM39E -2.65507 down MKI67IP 2.240789 up
NUCB1 -2.21584 down CLDND2 -2.05717 down CD44 2.1528 up
MATK -2.79759 down ADSSL1 -3.36535 down EFNB2 2.45524 up
TMEM137 -2.01238 down HIPK2 -2.82681 down NOC3L 2.085643 up
SUMF2 -2.38058 down RNASET2 -2.4344 down C14orf156 2.517158 up
MAP4 -2.01152 down RAB40C -2.04054 down SAFB 2.643532 up
H19 -2.06486 down LOC440991 -2.34873 down CPA4 4.110869 up
PALM -3.804 down TMEM44 -2.15751 down DHRS2 2.033563 up
SLC5A3 -2.52052 down ASS1 -2.35047 down ID3 2.00655 up
DUSP3 -2.76101 down KLK1 -4.50831 down CYP26B1 2.127379 up
CFD -2.4075 down C21orf2 -2.21645 down SNORD99 2.08307 up
BNIP3L -2.49273 down ACSF2 -2.68944 down ID2 2.360643 up
XYLT2 -2.119 down YIF1B -3.10022 down LOC728216 2.060811 up
ZBTB8A -2.3723 down NDUFS8 -2.1055 down BAZ1A 2.002185 up
PFKL -2.05159 down DGCR6 -2.00791 down TSEN2 2.141856 up
ANKRD9 -3.9042 down LOC100132535 -2.15071 down SERPINE2 2.190654 up
GCGR -2.37948 down FTHL2 -2.27598 down RNU6-15 8.252 up
AFAP1 -2.23707 down WDR54 -3.34919 down RNU1G2 2.35375 up
LOC644774 -3.31967 down BCKDHA -3.36516 down AADACL4 2.169888 up
WISP2 -2.17586 down PEMT -2.08253 down BDNF 2.537899 up
CARHSP1 -2.25964 down CSPG4 -3.14984 down LOC646723 2.195141 up
ENO3 2.02709 down SIPA1 -2.37067 down PSMG1 2.061627 up
SEC63 -3.61088 down ACSS2 -2.64571 down CYR61 2.33645 up
LANCL1 -2.14529 down LOC402538 -2.1107 down ZMPSTE24 2.423028 up
SFMBT2 -2.79924 down LUC7L -2.55621 down DKK1 3.761853 up
FTHL11 -2.51301 down ERCC1 -2.04642 down CTGF 2.747642 up
BNIP3 -4.01959 down NGFRAP1 -2.30981 down MSX1 2.368488 up
C17orf61 -2.00805 down FAM13A -2.17434 down NSUN2 2.378491 up
RNU11 -2.94907 down LOC100132532 -2.47989 down ITPR1 2.462272 up
GAPDHL6 -2.72929 down SLC25A23 -2.54784 down LOC642393 3.323373 up
NDRG1 -4.52317 down FAM158A -2.0648 down RN5S9 17.56618 up
ARL2 -3.57898 down IDH2 -3.19883 down HSPH1 2.142729 up
TAF13 -2.27729 down SLC35C2 -2.34899 down LOC100132564 3.166493 up
TAF13 -2.36237 down RPN2 -2.01864 down RNU6-1 9.159763 up
HMGCS1 -2.31274 down MIR1974 -3.90058 down CSTF3 2.687383 up
MAPK3 -2.57397 down TCEA2 -2.12453 down SNORD3D 23.12603 up
IL32 -2.29642 down SYMPK -2.33338 down RNU1F1 3.338085 up
RAB13 -4.23306 down C2orf82 -2.05978 down ANKRD11 2.237232 up
FOXO4 -2.42097 down CNNM3 -2.48002 down RNU1-3 2.226817 up
NFIC -3.84379 down ISYNA1 -2.09615 down CTGF 4.035205 up
RNF165 -2.60303 down LOC100132288 -3.09848 down LOC644743 2.194752 up
LOC729992 -2.01011 down MLXIPL -2.6806 down ZNF622 2.11719 up
ALDH3B1 -2.10165 down ALDH3A1 -2.33893 down LOC85389 5.139087 up
DCXR -2.19327 down C1QTNF6 -2.33846 down KRT13 2.030385 up
TIAF1 -2.33313 down NR2F1 -2.98172 down TIMM10 2.325743 up
LOC387825 -2.03243 down RAD21 -2.36823 down SOX17 2.142273 up
FTHL3 -2.51123 down LRP5 -2.18961 down LOC100008589 2.830091 up
SPC24 -2.04308 down NUCKS1 -2.02288 down LOC100008589 4.945028 up
SLC29A4 -2.58916 down NR1H3 -2.3109 down DIO2 2.201815 up
DRD4 -4.1909 down TMEM91 -2.34252 down FBN2 4.018469 up
TMEM45A -2.47835 down PICK1 -3.41846 down RNU1A3 3.809543 up
LOC732165 -2.00188 down BACE2 -2.00435 down SNORD83B 4.58666 up
HOXA11AS -2.33246 down VEGFB -3.33903 down COL4A5 2.161077 up
FTH1 -2.28801 down PPFIA4 -2.43137 down LOC100132394 7.930195 up
HPCAL1 -2.05276 down 6-Mar -2.20292 down C20orf24 2.21874 up
P4HTM -2.08118 down CDCP1 -2.21917 down GNG11 2.536727 up
SEMA3B -2.01048 down LOC100129681 -2.23543 down HNRPM 2.27823 up
SIL1 -2.7212 down GAPDH -3.72725 down LOC644033 2.345024 up
MT1X -3.91236 down GAPDH -2.5513 down KREMEN2 2.07181 up
LOC729708 -2.26521 down GAPDH -2.83752 down ODC1 2.658591 up
MTE -2.2616 down LOC255783 -2.31377 down UCN2 3.664276 up
CNFN -2.64449 down LOC729009 -2.09227 down MED10 2.382768 up
C17orf49 -2.19878 down CA9 -4.97239 down FOXC1 3.688892 up
ACSS2 -2.5716 down DPP7 -2.09268 down C20orf199 2.19874 up
ABCB7 -2.31913 down MC1R -2.08083 down KIAA1666 5.516031 up
WSB1 -2.33728 down LOC391075 -3.35654 down RNU4-2 3.666893 up
WSB1 -4.53343 down TOM1 -2.24006 down RNU1-5 2.101672 up
LOC286016 -2.56499 down ANGPTL4 -3.56429 down DCBLD2 2.124149 up
LCAT -2.59441 down HOXC4 -2.70585 down COL7A1 2.209354 up
MT2A -3.52737 down PLEKHN1 -2.43137 down LOC100008588 2.152983 up
UBXN6 -2.46764 down TMUB1 -2.3716 down C20orf24 2.253316 up
ENO2 -4.53821 down SEZ6L2 -2.23582 down LOC100134364 2.357778 up
NUCKS1 -2.33179 down PRNPIP -2.54991 down ALB 3.306516 up
C21orf58 -2.12242 down ANKRD33 -2.16356 down LOC652235 2.040471 up
RAB4B -2.15139 down ZNF526 -2.58858 down SNORD10 4.737826 up
SFN -2.2933 down WFDC1 -2.05472 down SLC38A2 2.039199 up
ITGA5 -3.35222 down TRAPPC6A -2.44657 down IFIT2 2.073076 up
LOX -3.4269 down DGCR6 -2.05774 down DNMT1 2.022657 up
MT1A -3.23128 down HCFC1R1 -3.06927 down RNU4-1 5.894303 up
LOC401252 -2.46926 down HCFC1R1 -3.76447 down SNORD3C 36.81438 up
DSEL -3.96844 down PTOV1 -2.09268 down RNU12 2.183622 up
FSCN2 -2.11908 down FAM162A -3.0414 down IGF2BP3 2.068923 up
ALDOC -7.30546 down ALDOA -2.28242 down CALD1 2.131286 up
CD68 -2.25926 down SLC16A3 -2.5165 down SNORA67 2.211227 up
P2RY11 -2.00458 down MUC1 -2.29842 down RPPH1 2.029684 up
DNAJB2 -2.24918 down RPL14 -3.42951 down PPAP2B 2.075177 up
LOC100131713 -2.1291 down PDDC1 -2.07092 down SNORA73A 2.114524 up
C12orf10 -2.13759 down TMEM205 -2.01323 down FAM179A 2.471054 up
LOC388076 -2.05928 down PDE9A -2.5926 down RN7SK 6.741672 up
SLC6A10P -3.11781 down PRKCSH -2.03108 down RN7SK 10.69681 up
CSNK1E -2.33995 down CAPZB -2.00726 down ASPM 2.49661 up
VKORC1 -2.82645 down HOXC10 -2.20101 down TXNDC14 2.025069 up
BCKDK -3.0848 down TLE6 -2.2353 down ERH 2.325561 up
OPA3 -2.14989 down C14orf78 -2.0409 down PTPLAD1 2.064264 up
C12orf11 -2.27695 down GPI -2.63082 down DUSP1 2.493636 up
NDUFA4L2 -3.5262 down PTP4A2 -2.34826 down TXNRD1 2.00262 up
SLC2A3 -3.09976 down PC -2.14352 down HINT3 4.739621 up
RRBP1 -2.11126 down C11orf80 -2.46962 down LOC642035 4.515363 up
KRT17 -2.21779 down CDT1 -2.22267 down ANXA1 2.227672 up
MED16 -2.10614 down HIST1H1C -2.5455 down SNORD3A 26.58271 up
ERI3 -2.78666 down LHPP -2.50539 down SNORD12C 2.324122 up
TMEM219 -2.14872 down LOC -2.02106 down GTPBP4 2.188588 up
Abbreviations: [FC: Fold Change.]

 

CONCLUSION

This in vitro study presents the altering in gene expression and pathway analysis of gamma irradiation in cervical cancer C-4 I cells. This study reveals that gamma radiation induced the proapoptosis Bid, Bik, Traf2, Traf3, Traf6, Tnf, Tnfrsf10b, Tnfrsf10d and other gene expressions in C-4 I cells presumably and it may be a down-regulator of some anti-apoptotic gene expression levels. These results indicate that single dose of γ-60Co irradiation primarily affects C-4 I cells proliferation by inducing the intrinsic and extrinsic apoptotic pathways. Identification of specific genes may allow the determination of pathways important in radiation responses, that it may be beneficial in novel treatment strategy to increase the cancer cell sensitivity to radiotherapy by modulation of many genes expression.

ACKNOWLEDGEMENTS

This study was supported by project number 25190 of the Research Fund at University of ?stanbul.

REFERENCES

1. Nair S, Nair RR, Srinivas P, Srinivas G, Pillai MR. Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway. Mol Carcinog. 2008; 47: 22-33.

2. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, et al. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 2011; 301: 185-192.

3. Bhosle SM, Huilgol NG, Mishra KP. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: Evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients. Cancer Detection and Prevention. 2005; 29: 369-375.

4. Wyllie AH. “Where, O death, is thy sting?” A brief review of apoptosis biology. Mol Neurobiol. 2010; 42: 4-9.

5. John H, Maduro MD, Elisabeth GE, De Vries MD, Gert-Jan M, Brigitt, MT, et al. Targeting Pro- Apoptotic TRAIL Receptors Sensitizes HeLa Cervical Cancer Cells to Irradiation-Induced Apoptosis. Int J Radiat Oncol Biol Phys. 2008; 72: 543-552.

6. Eriksson D, Löfroth PO, Johansson L, Riklund K, Stigbrand T. Apoptotic signalling in HeLa Hep2 cells following 5 Gy of cobalt-60 gamma radiation. Anticancer Res. 2009; 29: 4361-4366.

7. Frenzel A, Grespi F, Chmelewskij W, Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 2009; 14: 584-596.

8. Jiang B, Liang P, Deng G, Tu Z, Liu M, Xiao X. Increased stability of Bcl-2 in HSP70-mediated protection against apoptosis induced by oxidative stress. Cell Stress Chaperones. 2010; 16:143-152.

9. Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ. 2009; 16: 1053-1061.

10. Zhou Y, Feng X, Koh DW. Activation of Cell Death Mediated by Apoptosis-Inducing Factor Due to the Absence of Poly(ADP-ribose) Glycohydrolase. Biochemistry. 2011; 50: 2850-2859.

11. Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, et al. P53- mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human brea... Acta Pharmacol Sin. 2007; 28: 1057-1066.

12. Bian J, Wang X, Yun J, Cao R, Cao Y, Liang J, et al. Single-fraction γ-60Co radiation induces apoptosis in cultured rat C6 cells. Ann Saudi Med. 2012; 32: 269-275.

13. Arican GO, Khalilia W, Serbes U, Akman G, Cetin I, Arican E. Effects of hypobaric conditions on apoptosis signalling pathways in HeLa cells. APJCP. 2014; 15; 5043-5047.

14. Banáth JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004; 64: 7144-7149.

15. Smirnov DA, Brady L, Halasa K, Morley M, Solomon S, Cheung VG. Genetic variation in radiation-induced cell death. Genome Res. 2012; 22: 332-339.

16. zcan Arican G, akir , Arican E, Turgut Kara N, Dagdeviren , Ari S. Effects of Geven root extract on proliferation of HeLa cells and bcl-2 gene expressions, African Journal of Biotechnology. 2012; 11: 4296-4304.

17. Gieseler RK, Marquitan G, Schlatt JM, Sowa L P, Bechmann J, Timm M, et al. Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. J Viral Hepat. 2011; 18: 760-767.

18. Hrvatin S, O’Donnell CW, Deng F, Millman JR, Pagliuca FW, DiIorio P, et al. Differentiated human stem cells resemble fetal, not adult, β cells. Proc Natl Acad Sci U S A. 2014; 111: 3038-3043.

19. Pera J, Korostynski M, Krzyszkowski T, Czopek J, Slowik A, Dziedzic T, et al. Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation? Stroke. 2010; 41: 224-231.

20. Reinholz MM, Eckel-Passow JE, Anderson SK, Asmann YW, Zschunke MA, Oberg AL, et al. Expression profiling of formalin-fixed paraffin embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL platform. BMC Medical Genomics. 2010; 3: 60.

21. Mi H and Thomas P. PANTHER Pathway: An Ontology-Based Pathway Database Coupled with Data Analysis Tools. Methods Mol Biol. 2009; 123-140.

22. Wilkie GS, Gautier P, Lawson D, Gray NK. Embryonic Poly(A)-Binding Protein Stimulates Translation in Germ Cells. Mol Cellular Biol. 2005; 25: 2060-2071.

23. Willems E, Leyns L, Vandesompele J. Standardization of real-time PCR gene expression data from independent biological replicates. Anal Biochem. 2008; 379: 127-129.

24. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007; 8: R19.

25. Liu SS, Chan KY, Leung RC, Law HK, Leung TW, Ngan HY. Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73alpha. Mol Cancer Ther. 2006; 5: 1209-1215.

26. Maduro JH, de Vries EGE, Meersma GJ, Hougardy BMT, van der Zee AGJ, de Jong S. Targeting Pro-Apoptotic TRAIL Receptors Sensitizes HeLa Cervical Cancer Cells to Irradiation-Induced Apoptosis. IJR OBP. 2008; 72: 543-552.

27. Feng J, Sheng H, Zhu C, Jiang H, Ma S. Effect of Adjuvant Magnetic Fields in Radiotherapy on Non-Small-Cell Lung Cancer Cells In Vitro. BioMed Res Int. 2013; e657259.

28. Chaudhry MA. Analysis of gene expression in normal and cancer cells exposed to gamma-radiation. J Biomed Biotechnol. 2008; 541678.

29. Elkoreh G, Blais V, Béliveau E, Guillemette G, Denault JB. Type 1 inositol-,4,5-trisphosphate receptor is a late substrate of caspases during apoptosis. J Cell Biochem. 2012; 113: 2775-2284.

30. Liu F, Zheng S, Liu T, Liu Q, Liang M, Li X. et al. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway. Molecu Cellul Biochem. 2013; 381: 115-125.

31. Pucci B, Indelicato M, Paradisi V, Reali V, Pellegrini L, Aventaggiato M, et al. ERK-1 MAP kinase prevents TNF-induced apoptosis through bad phosphorylation and inhibition of Bax translocation in HeLa Cells. J Cell Biochem. 2009; 108: 1166-1174.

32. Buxade M, Parra-Palau JL, Proud CG. The Mnks: MAP kinaseinteracting kinases (MAP kinase signal-integrating kinases). Front Biosci. 2008; 13: 5359-5373.

33. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006; 25: 4633-4646.

34. Kim S, Zhang L. Identification of naturally secreted soluble form of TL1A, a TNF-like cytokine. J Immunol Methods. 2005; 298: 1-8.

35. Ihrie RA, Bronson RT, Attardi LD. Adult mice lacking the p53/p63 target gene Perp are not predisposed to spontaneous tumorigenesis but display features of ectodermal dysplasia syndr... Cell Death Differ. 2006; 13: 1614-1618.

36. Wang P, Lindsay J, Owens TW, Mularczyk EJ, Warwood S, Foster F, et al. Phosphorylation of the proapoptotic BH3-only protein bid primes mitochondria for apoptosis during mitotic arrest. Cell Rep. 2014; 7: 661-671.

37. Garcia-Perez C, Roy SS, Naghdi S, Lin X, Davies E, Hajnczky G. BID-induced mitochondrial membrane permeabilization waves propagated by local reactive oxygen species (ROS) signaling. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109: 4497-4502.

38. Wang Y, Tjandra N. Structural insights of tBid, the caspase-8-activated Bid, and its BH3 domain. J Biol Chem. 2013; 288: 35840-35851.

39. Certo M, Del Gaizo, Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA, et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell. 2006; 9: 351-365.

40. Hur J, Bell DW, Dean KL, Coser KR, Hilario PC, Okimoto RA, et al. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. Cancer Res. 2006; 66: 10153-10161.

41. Jiao S, Wu M, Ye F3, Tang H, Xie X, Xie X. BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer. PLoS One. 2014; 9: 92172.

42. Loriot Y, Mordant P, Dugue D Geneste O, Gombos A, Opolon P, et al. Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer. Cell Death Dis. 2014; 5: e1423.

43. Wu H, Schiff DS, Lin Y, Neboori HJ, Goyal S, Feng Z, et al. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1. Radiat Res. 2014; 182: 618-625.

Received : 23 Nov 2016
Accepted : 14 Feb 2017
Published : 21 Feb 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X